Lefamulin: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 March 2025

  • curprev 21:0321:03, 9 March 2025 Omid Afkhami-Ardakani talk contribs 6,506 bytes +6,506 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Lefamulin |aOrAn=a |drugClass=Pleuromutilin Antibiotic |indicationType=treatment |indication=adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms. |adverseReactions=injection: administration site reactions, hepatic enzyme elevation, nausea, hypokalemia, insomnia, headache.​ Oral: diarrhea, nausea, vomiting, hepatic enzyme elevation. |blackBoxWarningTit..."